Physician profile
Christopher Chung
NPI 1215484605
$4,846.70
in general payments reported to CMS, 2019-2025
8 companies · $345 in 2025
The $345 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $126 · 2022: $580 · 2023: $923 · 2024: $2,872 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,420 · Travel and Lodging: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,420.02 |
| Travel and Lodging | $720.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,198.21 | 2022-2025 | Hydrus Microstent, Clareon, Centurion |
| Abbvie INC. | $362.26 | 2024-2025 | |
| Dutch Ophthalmic, USA | $339.32 | 2024 | Tissueblue, Eva, Combined Machine |
| Bausch & Lomb Americas INC. | $238.35 | 2024-2025 | Stellaris |
| Regeneron Healthcare Solutions, INC. | $199.25 | 2024 | Eylea Hd |
| Glaukos Corporation | $136.62 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Horizon Therapeutics Plc | $125.00 | 2023 | Tepezza |
| Astellas Pharma US INC | $121.81 | 2024 | Izervay |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.